Detalhe da pesquisa
1.
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study.
Ann Oncol
; 33(6): 616-627, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35337972
2.
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study.
Ann Oncol
; 32(12): 1571-1581, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34656740
3.
Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study.
Clin Transl Oncol
; 9(5): 317-22, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17525042
4.
Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials.
Lung Cancer
; 85(3): 408-14, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25088661
5.
Regulation of nuclear factor kappa B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C zeta in c-Rel activation by tumor necrosis factor alpha.
J Biol Chem
; 276(19): 15840-9, 2001 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-11278885